{"id":"W2620097568","doi":"10.1016/j.jtho.2017.05.019","title":"Scientific Advances in Thoracic Oncology 2016","year":2017,"lang":"en","type":"review","venue":"Journal of Thoracic Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Foundation Medicine; Loxo Oncology; Pharmacyclics; Chugai Pharmaceutical; EMD Serono; Genentech; Medela; Astellas Pharma; Daiichi-Sankyo; Taiho Pharmaceutical; National Institutes of Health; Regeneron Pharmaceuticals; Meiji Seika Pharma; American Cancer Society; Shionogi; Helsinn; Mirati Therapeutics; Clovis Oncology; Varian Medical Systems; Ariad Pharmaceuticals; Cancer Research UK; Array BioPharma; National Cancer Institute; Gilead Sciences; Exelixis; Sanofi; G1 Therapeutics; Celgene; AstraZeneca; Ignyta; Eli Lilly and Company; Bristol-Myers Squibb; Pfizer","keywords":"Medicine; Lung cancer; Targeted therapy; Immunotherapy; Oncology; Radiation therapy; Internal medicine; Radiation oncology; Medical physics; Cancer; Intensive care medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001914731,0.000419483,0.003994627,0.001293335,0.0002313369,0.00008167926,0.0005589751,0.0007366934,0.0002205749],"category_scores_gemma":[0.0004883655,0.0002720445,0.0008467315,0.000374101,0.0004395757,0.0004603816,0.0001079818,0.001300938,0.000160353],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002991627,"about_ca_system_score_gemma":0.01267485,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000092871,"about_ca_topic_score_gemma":0.0001147657,"domain_scores_codex":[0.9963962,0.0005754029,0.001701613,0.0004405417,0.0004046631,0.000481516],"domain_scores_gemma":[0.9944929,0.0004480242,0.003587911,0.0006379883,0.0005144349,0.0003186642],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002648219,0.0006662498,0.00003127014,0.004740119,0.0003939433,0.00267764,0.0001728024,0.000001235915,0.000001059291,0.00002059106,0.00471855,0.9863117],"study_design_scores_gemma":[0.0006214203,0.001950015,0.00003614861,0.01666195,0.005202749,0.005214324,0.00009200566,0.000001062578,0.00000194708,0.0002260665,0.9697905,0.0002018083],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00004618203,0.9706821,0.0000339837,0.001158528,0.005516968,0.0007811839,0.00003601779,0.00001252147,0.02173253],"genre_scores_gemma":[0.00007789357,0.9855449,0.002556884,0.00009569005,0.001060116,0.00006053309,0.00005261407,0.00005116522,0.01050021],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9861099,"threshold_uncertainty_score":0.9999732,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09726148855054398,"score_gpt":0.5912693878452375,"score_spread":0.4940078992946936,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}